1. Home
  2. WOR vs KYMR Comparison

WOR vs KYMR Comparison

Compare WOR & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WOR
  • KYMR
  • Stock Information
  • Founded
  • WOR 1955
  • KYMR 2015
  • Country
  • WOR United States
  • KYMR United States
  • Employees
  • WOR N/A
  • KYMR N/A
  • Industry
  • WOR Aerospace
  • KYMR Medicinal Chemicals and Botanical Products
  • Sector
  • WOR Consumer Discretionary
  • KYMR Health Care
  • Exchange
  • WOR Nasdaq
  • KYMR Nasdaq
  • Market Cap
  • WOR 3.0B
  • KYMR 3.1B
  • IPO Year
  • WOR N/A
  • KYMR 2020
  • Fundamental
  • Price
  • WOR $64.69
  • KYMR $42.39
  • Analyst Decision
  • WOR Buy
  • KYMR Strong Buy
  • Analyst Count
  • WOR 3
  • KYMR 16
  • Target Price
  • WOR $63.67
  • KYMR $58.94
  • AVG Volume (30 Days)
  • WOR 224.9K
  • KYMR 608.2K
  • Earning Date
  • WOR 09-23-2025
  • KYMR 08-11-2025
  • Dividend Yield
  • WOR 1.04%
  • KYMR N/A
  • EPS Growth
  • WOR N/A
  • KYMR N/A
  • EPS
  • WOR 1.92
  • KYMR N/A
  • Revenue
  • WOR $1,153,762,000.00
  • KYMR $44,711,000.00
  • Revenue This Year
  • WOR $13.63
  • KYMR $58.26
  • Revenue Next Year
  • WOR $4.73
  • KYMR N/A
  • P/E Ratio
  • WOR $33.89
  • KYMR N/A
  • Revenue Growth
  • WOR N/A
  • KYMR N/A
  • 52 Week Low
  • WOR $37.88
  • KYMR $19.45
  • 52 Week High
  • WOR $70.91
  • KYMR $53.27
  • Technical
  • Relative Strength Index (RSI)
  • WOR 58.15
  • KYMR 47.73
  • Support Level
  • WOR $62.11
  • KYMR $36.65
  • Resistance Level
  • WOR $67.10
  • KYMR $44.94
  • Average True Range (ATR)
  • WOR 1.29
  • KYMR 1.60
  • MACD
  • WOR 0.26
  • KYMR -0.21
  • Stochastic Oscillator
  • WOR 66.04
  • KYMR 65.38

About WOR Worthington Enterprises Inc.

Worthington Enterprises Inc is a designer and manufacturer of products sold to consumers, through retail channels, in the tools, outdoor living and celebrations market categories as well as a wide array of specialized building products that serve customers in the residential and non-residential construction markets, including ceiling suspension systems and light gauge metal framing products, as well as wholly-owned and consolidated operations that produce pressurized containment solutions for heating, cooking and cooling applications, among others. It operates under two reportable operating segments: Consumer Products and Building Products. It derives majority of the revenue from Building Products segment.

About KYMR Kymera Therapeutics Inc.

Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.

Share on Social Networks: